Your Cart

Imagion Biosystems Limited Risk Management Statement

Imagion Biosystems Limited Risk Management Statement

Imagion Biosystems Limited (Company) is committed to establishing a sound system of risk oversight and management and internal control to identify, assess, monitor and manage material risks related to the conduct of the Company’s activities.
Read the Imagion Biosystems Limited Risk Management Statement.

Related Articles

1H2023 Half-Year Results

1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.